FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978345721> ?p ?o ?g. }

• W1978345721 endingPage "185" @default.
• W1978345721 startingPage "179" @default.
• W1978345721 abstract "Mantle cell lymphoma (MCL) is an aggressive B-cell lymphoma with poor clinical outcome. Although front therapy induces a high rate of complete remission (CR), relapse is inevitable and new regimens are much needed for relapsed MCL. The proteasome inhibitor bortezomib (BTZ) induces apoptosis and sensitizes MCL cells to chemotherapy in relapsed MCL, but CR rates are low, with a short duration of response and severe toxicity. Here we evaluated whether BTZ is additive or synergistic with cyclophosphamide (CTX) and rituximab (RTX). Increasing doses of BTZ with a fixed dose of RTX and CTX (BRC regimen) resulted in markedly synergistic growth inhibition of MCL cells. BRC significantly enhanced apoptosis in MCL cell lines and primary tumor cells compared with single-agent treatment. Furthermore, western blotting analysis indicated that BRC induces apoptosis earlier via activation and cleavage of caspases-8, -9 and -3, and poly (ADP-ribose) polymerase, than single-agent treatment. The pan-caspase inhibitor completely blocked apoptosis induced by BRC. In vivo studies showed that BRC eradicated subcutaneous tumors in MCL-bearing SCID mice and significantly prolonged the long-term event-free survival in 70% of the mice. Hence, our study demonstrates that cytoreductive chemotherapy with both BTZ and anti-CD20 antibody may offer a better therapeutic modality for relapsed MCL." @default.
• W1978345721 created "2016-06-24" @default.
• W1978345721 creator A5004439239 @default.
• W1978345721 creator A5008382997 @default.
• W1978345721 creator A5027513506 @default.
• W1978345721 creator A5053708169 @default.
• W1978345721 creator A5058744266 @default.
• W1978345721 creator A5063946500 @default.
• W1978345721 creator A5074743570 @default.
• W1978345721 creator A5084566787 @default.
• W1978345721 creator A5089736242 @default.
• W1978345721 date "2007-09-27" @default.
• W1978345721 modified "2023-10-12" @default.
• W1978345721 title "Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo" @default.
• W1978345721 cites W1945251789 @default.
• W1978345721 cites W1980470989 @default.
• W1978345721 cites W2032870664 @default.
• W1978345721 cites W2042895990 @default.
• W1978345721 cites W2063779563 @default.
• W1978345721 cites W2067653691 @default.
• W1978345721 cites W2068786168 @default.
• W1978345721 cites W2074610455 @default.
• W1978345721 cites W2084925682 @default.
• W1978345721 cites W2092502635 @default.
• W1978345721 cites W2100608938 @default.
• W1978345721 cites W2104067910 @default.
• W1978345721 cites W2108063064 @default.
• W1978345721 cites W2119680582 @default.
• W1978345721 cites W2125684345 @default.
• W1978345721 cites W2130093747 @default.
• W1978345721 cites W2136735139 @default.
• W1978345721 cites W2141765139 @default.
• W1978345721 cites W2147422161 @default.
• W1978345721 cites W2151092645 @default.
• W1978345721 cites W2170362988 @default.
• W1978345721 doi "https://doi.org/10.1038/sj.leu.2404959" @default.
• W1978345721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17898787" @default.
• W1978345721 hasPublicationYear "2007" @default.
• W1978345721 type Work @default.
• W1978345721 sameAs 1978345721 @default.
• W1978345721 citedByCount "87" @default.
• W1978345721 countsByYear W19783457212012 @default.
• W1978345721 countsByYear W19783457212013 @default.
• W1978345721 countsByYear W19783457212014 @default.
• W1978345721 countsByYear W19783457212015 @default.
• W1978345721 countsByYear W19783457212016 @default.
• W1978345721 countsByYear W19783457212017 @default.
• W1978345721 countsByYear W19783457212018 @default.
• W1978345721 countsByYear W19783457212019 @default.
• W1978345721 countsByYear W19783457212021 @default.
• W1978345721 countsByYear W19783457212023 @default.
• W1978345721 crossrefType "journal-article" @default.
• W1978345721 hasAuthorship W1978345721A5004439239 @default.
• W1978345721 hasAuthorship W1978345721A5008382997 @default.
• W1978345721 hasAuthorship W1978345721A5027513506 @default.
• W1978345721 hasAuthorship W1978345721A5053708169 @default.
• W1978345721 hasAuthorship W1978345721A5058744266 @default.
• W1978345721 hasAuthorship W1978345721A5063946500 @default.
• W1978345721 hasAuthorship W1978345721A5074743570 @default.
• W1978345721 hasAuthorship W1978345721A5084566787 @default.
• W1978345721 hasAuthorship W1978345721A5089736242 @default.
• W1978345721 hasBestOaLocation W19783457211 @default.
• W1978345721 hasConcept C126322002 @default.
• W1978345721 hasConcept C150903083 @default.
• W1978345721 hasConcept C185592680 @default.
• W1978345721 hasConcept C190283241 @default.
• W1978345721 hasConcept C203014093 @default.
• W1978345721 hasConcept C207001950 @default.
• W1978345721 hasConcept C2776364478 @default.
• W1978345721 hasConcept C2776694085 @default.
• W1978345721 hasConcept C2776755627 @default.
• W1978345721 hasConcept C2777478702 @default.
• W1978345721 hasConcept C2777525834 @default.
• W1978345721 hasConcept C2778367456 @default.
• W1978345721 hasConcept C2779338263 @default.
• W1978345721 hasConcept C502942594 @default.
• W1978345721 hasConcept C55493867 @default.
• W1978345721 hasConcept C71924100 @default.
• W1978345721 hasConcept C86803240 @default.
• W1978345721 hasConcept C98274493 @default.
• W1978345721 hasConceptScore W1978345721C126322002 @default.
• W1978345721 hasConceptScore W1978345721C150903083 @default.
• W1978345721 hasConceptScore W1978345721C185592680 @default.
• W1978345721 hasConceptScore W1978345721C190283241 @default.
• W1978345721 hasConceptScore W1978345721C203014093 @default.
• W1978345721 hasConceptScore W1978345721C207001950 @default.
• W1978345721 hasConceptScore W1978345721C2776364478 @default.
• W1978345721 hasConceptScore W1978345721C2776694085 @default.
• W1978345721 hasConceptScore W1978345721C2776755627 @default.
• W1978345721 hasConceptScore W1978345721C2777478702 @default.
• W1978345721 hasConceptScore W1978345721C2777525834 @default.
• W1978345721 hasConceptScore W1978345721C2778367456 @default.
• W1978345721 hasConceptScore W1978345721C2779338263 @default.
• W1978345721 hasConceptScore W1978345721C502942594 @default.
• W1978345721 hasConceptScore W1978345721C55493867 @default.
• W1978345721 hasConceptScore W1978345721C71924100 @default.
• W1978345721 hasConceptScore W1978345721C86803240 @default.
• W1978345721 hasConceptScore W1978345721C98274493 @default.

• next